The Novel LncRNA BlackMamba Controls the Neoplastic Phenotype of ALK Anaplastic Large Cell Lymphoma by Regulating the DNA Helicase HELLS
Overview
Authors
Affiliations
The molecular mechanisms leading to the transformation of anaplastic lymphoma kinase negative (ALK) anaplastic large cell lymphoma (ALCL) have been only in part elucidated. To identify new culprits which promote and drive ALCL, we performed a total transcriptome sequencing and discovered 1208 previously unknown intergenic long noncoding RNAs (lncRNAs), including 18 lncRNAs preferentially expressed in ALCL. We selected an unknown lncRNA, BlackMamba, with an ALK ALCL preferential expression, for molecular and functional studies. BlackMamba is a chromatin-associated lncRNA regulated by STAT3 via a canonical transcriptional signaling pathway. Knockdown experiments demonstrated that BlackMamba contributes to the pathogenesis of ALCL regulating cell growth and cell morphology. Mechanistically, BlackMamba interacts with the DNA helicase HELLS controlling its recruitment to the promoter regions of cell-architecture-related genes, fostering their expression. Collectively, these findings provide evidence of a previously unknown tumorigenic role of STAT3 via a lncRNA-DNA helicase axis and reveal an undiscovered role for lncRNA in the maintenance of the neoplastic phenotype of ALKALCL.
Exploring the transcriptional cooperation between RUNX2 and its associated elncRNA RAIN.
Vitale E, Manicardi V, Gugnoni M, Torricelli F, Donati B, Muccioli S Cell Death Dis. 2024; 15(9):673.
PMID: 39271656 PMC: 11399121. DOI: 10.1038/s41419-024-07058-x.
Tameni A, Mallia S, Manicardi V, Donati B, Torricelli F, Vitale E Nucleic Acids Res. 2024; 52(11):6171-6182.
PMID: 38597676 PMC: 11194065. DOI: 10.1093/nar/gkae239.
Long Non-Coding RNA Signatures in Lymphopoiesis and Lymphoid Malignancies.
Baghdadi H, Heidari R, Zavvar M, Ahmadi N, Khomartash M, Vahidi M Noncoding RNA. 2023; 9(4).
PMID: 37624036 PMC: 10458434. DOI: 10.3390/ncrna9040044.
Mularoni V, Donati B, Tameni A, Manicardi V, Reggiani F, Sauta E Haematologica. 2023; 108(12):3333-3346.
PMID: 37381763 PMC: 10690924. DOI: 10.3324/haematol.2022.282552.
Zhao A, Zhou H, Yang J, Li M, Niu T Signal Transduct Target Ther. 2023; 8(1):71.
PMID: 36797244 PMC: 9935927. DOI: 10.1038/s41392-023-01342-6.